Regulus Therapeutics Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. for February 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 06 2019 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Option Exercise | A | 0.95 | 40,000 | 38,000 | 40,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Grant | A | 0.95 | 40,000 | 38,000 | 62,893 | 22.9 K to 62.9 K (+174.73 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.95 | 65,000 | 61,750 | 65,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.95 | 65,000 | 61,750 | 84,148 | 19.1 K to 84.1 K (+339.46 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.95 | 30,000 | 28,500 | 34,578 | 4.6 K to 34.6 K (+655.31 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Aker Christopher Ray | Sr. VP & General Co ... | Option Exercise | A | 0.95 | 25,000 | 23,750 | 25,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Aker Christopher Ray | Sr. VP & General Co ... | Grant | A | 0.00 | 25,000 | 0 | 27,747 | 2.7 K to 27.7 K (+910.08 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Option Exercise | A | 0.95 | 40,000 | 38,000 | 40,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | WRIGHT TIMOTHY MICHAEL | Chief R & D Officer | Grant | A | 0.95 | 40,000 | 38,000 | 62,893 | 22.9 K to 62.9 K (+174.73 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Option Exercise | A | 0.95 | 65,000 | 61,750 | 65,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Hagan Joseph P | President and CEO | Grant | A | 0.95 | 65,000 | 61,750 | 84,148 | 19.1 K to 84.1 K (+339.46 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.95 | 30,000 | 28,500 | 34,578 | 4.6 K to 34.6 K (+655.31 %) |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Aker Christopher Ray | Sr. VP & General Co ... | Option Exercise | A | 0.95 | 25,000 | 23,750 | 25,000 | |
Feb 06 2019 | RGLS | Regulus Therapeuti ... | Aker Christopher Ray | Sr. VP & General Co ... | Grant | A | 0.00 | 25,000 | 0 | 27,747 | 2.7 K to 27.7 K (+910.08 %) |